ALFA Finder| Management target | Revenue 100.0% FY28 |
|---|
| Revenue growth | 165% YoY surge driven by US energy sector consolidation. |
|---|---|
| Margins | Consolidated margins expanded to 15.7% via better product mix. |
| Demand visibility | Strong outlook for US oilfield chemicals and sustainable textile solutions. |
| Management confidence | Balanced; extremely bullish on US energy and green chemistry synergy. |
Growth
165% YoY revenue growth; EBITDA margins expanded to 15.7% from 13.9% last quarter.
Outlook
Targeting $200 million revenue from CrudeChem by FY28, doubling FY27 guidance of $100 million.
Risks
Heavy dependence on US oilfield volatility and Middle East geopolitical impacts on raw material costs.
Earnings Call Transcript filed with BSE, NSE: FCL. Summary written with AI assistance from the document.
Fineotex Chemical Ltd: key numbers
- Share price
- ₹51.50
- Market cap
- ₹5,997 Cr
- Revenue (annual)
- ₹772.2 Cr
- Net profit (annual)
- ₹108.8 Cr
- P/E (TTM)
- 49.0×Sector 35.5×
- Promoter holding
- 62.30%+0.00% QoQ
- FII holding
- 2.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fineotex Chemical Ltd
All →Fineotex Chemical Board Meeting Date
Fineotex Chemical Ltd has scheduled a board meeting on November 13, 2026. The board will consider unaudited financial results for the quarter and half-year ended September 30, 2026.
Fineotex Chemical Merger & Restructuring Worth ₹0.05 Cr
Fineotex Chemical's subsidiary, Fineotex Biotex HealthGuard FZE, incorporated a new US-based subsidiary, Fineotex America Inc., for ₹0.05 Crore to provide specialized water treatment solutions.
- Value
- ₹0.05 Cr
Fineotex Chemical Merger & Restructuring
Fineotex Chemical's FZE subsidiary incorporated Fineotex America Inc. in Delaware, USA. The entity will supply water treatment chemicals for data centers and semiconductors.
Fineotex Chemical Annual General Meeting
Fineotex Chemical Limited conducted its 23rd Annual General Meeting on September 11, 2026. Shareholders discussed ordinary and special business items, including dividend and fund raising proposals.
Fineotex Chemical Merger & Restructuring Worth ₹0.05 Cr
Fineotex Chemical's subsidiary, Fineotex Biotex HealthGuard FZE, incorporated a new wholly-owned subsidiary, Fineotex Holdings Inc., in the USA for specialty chemical business activities.
- Value
- ₹0.05 Cr
Fineotex Chemical Merger & Restructuring
Fineotex Chemical Limited incorporated a new wholly-owned step-down subsidiary, Fineotex Holdings Inc., in the USA. This entity will pursue specialty chemical and growth opportunities.